Related Experiment Video
Updated: Aug 7, 2026

Prostaglandin Extraction and Analysis in Caenorhabditis elegans
Published on: June 25, 2013
Prostaglandin E1: a review
1Department of Biology, Roche Products Ltd., Welwyn Garden City, Herts, UK.
Prostaglandin E1 (PGE1), widely available since the late sixties, has extensive biological and clinical data. This review focuses on recent findings regarding its mechanisms of action.
Area of Science:
- Biochemistry
- Pharmacology
- Organic Chemistry
Background:
- Prostaglandin E1 (PGE1) structure elucidation was completed 25 years ago.
- Chemical synthesis methods for prostaglandins (PG) with natural configuration were developed in the late sixties.
- PGE1 became widely available by the late sixties, leading to substantial accumulated information on its effects.
Purpose of the Study:
- To review the biological and clinical effects of Prostaglandin E1 (PGE1).
- To focus on recent studies investigating the mechanisms of action of PGE1.
Main Methods:
- Literature review of accumulated information on PGE1.
- Focus on recent studies concerning PGE1 mechanisms of action.
Main Results:
- Extensive information exists on the biological and clinical effects of PGE1.
- Recent studies have provided new insights into PGE1 mechanisms of action.
Conclusions:
- PGE1 is a well-studied prostaglandin with a significant body of research.
- Further investigation into PGE1's mechanisms of action is ongoing and yields new information.
More Related Videos
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Intrauterine Drug Delivery Systems